Association of Urinary Tract Infection With Preeclampsia During Pregnancy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-35
SponsorPakistan Air Force (PAF) Hospital Islamabad

About this trial

Urinary tract infections (UTIs) are a major clinical issue, especially in pregnant women, due to physiological changes that increase susceptibility. If untreated, UTIs can lead to severe complications like preterm labor and low birth weight. Preeclampsia, a hypertensive disorder affecting 0.2-9.2% of pregnancies, is another leading cause of maternal and fetal complications. The relationship between UTIs and preeclampsia remains controversial, with some studies suggesting an association while others show conflicting results. Research gaps highlight the need for region-specific studies, particularly in Pakistan, where both conditions contribute significantly to maternal and neonatal morbidity.

This study aims to investigate the association between UTIs and preeclampsia in pregnant women in Pakistan. It will use a cohort design, enrolling 160 patients (80 with UTIs, 80 without) from the Obstetrics Department of PAF Hospital, Islamabad. Participants will be followed until delivery, with preeclampsia diagnosed based on blood pressure and proteinuria criteria. Data will be analyzed using SPSS to calculate relative risk (RR), with statistical significance set at RR \>1 and p ≤ 0.05. The findings could help improve prenatal care and reduce adverse outcomes in high-risk populations.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients attending OPD for routine antenatal checkup

Patients diagnosed with UTI as per operational definitions

Gestational age greater than 20 weeks as per LMP

Age between 18 to 35 years

Disqualifiers

Diabetes mellitus

Chronic hypertension

Chronic liver or kidney diseases

Chronic pulmonary conditions

Trial population

Women with gestational amenorrhea coming for routine antenatal checkup

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Preeclampsia developed

    Other intervention

    Preecalmpsia will be defined as per study protocol

Treatment groups

160 Participants
are divided into 2 treatment groups
Group A: UTI exposed1 intervention
Group B: UTI non exposed1 intervention

Trial outcomes

Primary outcomes

1

Preeclampsia

It will be defined as BP \>140/90 mmHg on minimum two occasions after 20 weeks of pregnancy alongside presence of proteinuria (≥300 mg/day or at least 1+ dipstick testing or spot urine protein/creatinine ratio of ≥30 mg/mmol).

Time frame
37 weeks of pregnancy

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.